Le Lézard
Classified in: Health
Subject: MAT

Board-Certified Plastic Surgeon, Dr. William K. Boss, Jr. Explains His New One-Of-A-Kind Patented Procedure, Genlyft


NJ Top Docs has reviewed and approved Board-Certified Plastic Surgeon, Dr. William K. Boss, Jr. for 2022. Dr. Boss is the creator of a new patented procedure, GenLyfttm.

SCOTCH PLAINS, N.J., Oct. 5, 2022 /PRNewswire-PRWeb/ -- NJ Top Docs has reviewed and approved Board-Certified Plastic Surgeon, Dr. William K. Boss, Jr. for 2022. Dr. Boss is the creator of a new patented procedure, GenLyfttm.

Dr. William K. Boss, board-certified plastic surgeon, is a pioneer in cellular therapy. Dr. Boss has over three decades of experience developing minimally invasive procedures and is regularly conceiving new techniques such as his patented procedure, GenLyfttm.

GenLyfttm is a minimally invasive customizable face and or neck lift for all generations of men and women. It consists of five procedures and four technologies that can be performed in the office with local anesthesia in about 90 minutes. Recuperation is rapid with minimal discomfort and patients can return to work in about three to five days.

In the early 2000's, many face lift procedures, such as the "lifestyle lift" were being marketed as minimally invasive with quick recovery and could be done without general anesthesia. But unfortunately, the results were inconsistent, not long lasting, and did little to address the neck.

"I felt I had to find a way to create a minimally invasive face and neck lift that could be done under local anesthesia," says Dr. Boss.

"In the late 2000's I conceived of using heat from lasers and special deep sutures to lift and tighten skin with minimal incisions. The laser heat would tighten skin and the specialty sutures would lift the deep tissues including the neck muscles as part of a short scar face lift. Adding the laser and specialty sutures to a facelift added two new tightening techniques to the standard face lift. Eventually, my concept of adding heat to the deep tissues during the facelift and adding deep supporting specialized sutures was granted a patent in 2015," he adds.

Dr. Boss explains that the application of heat will cause collagen formation and tightening of the skin and deep tissues which continues for months, and the addition of liposuction causes a mechanical effect that also increases tightening. Finally, the addition of specialized fine lifting sutures to the deep tissues produces a deep "lift" without extensive dissection and hence less swelling.

Genlyft embraces all these elements and gives reliable results that usually continue to improve for many months to years after the procedure.

To learn more about NJ Top Doc, Dr. William K. Boss, Jr. and his patented procedure GenLyfttm please visit: https://njtopdocs.com/nj-doctors/drwilliamboss/

----

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Media Contact

Marissa Pane, NJ Top Docs, 908-288-7240, [email protected]

Twitter

 

SOURCE NJ Top Docs


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: